News
PAIN Sackler Activists Throw "Blood Money" and Stage Die-in Outside Purdue Pharma's Bankruptcy Hearing
“We’re not going to stop until they personally face charges,” Nan Goldin, founder of PAIN Sackler, declared.
News
“We’re not going to stop until they personally face charges,” Nan Goldin, founder of PAIN Sackler, declared.
News
“We want the Sacklers to have their day in court,” said an activist from PAIN Sackler at the protest in Connecticut. “We want to see all the documents of when they decided to poison the population in this country.”
In Brief
The family will provide a $3 billion payout over seven years. However, the settlement does not include a statement of wrongdoing.
News
The activists are calling on the governor to establish overdose prevention centers to combat the growing opioid epidemic.
In Brief
President of the Louvre Museum Jean-Luc Martinez denied any connection between the decision and a recent PAIN Sackler protest outside the museum.
In Brief
Smithsonian Secretary Lonnie G. Bunch wrote Senator Jeff Merkley that the Smithsonian is legally bound to maintain the name of Arthur M. Sackler.
News
The American Museum of Natural History also confirmed that it has stopped taking donations from the Sacklers associated with Purdue Pharma.
In Brief
“The Sacklers love putting their names on things. Although until very recently they have been miraculously good at keeping their name off the opioid crisis," Oliver quipped in the segment, making note of Nan Goldin's art world protests against the family.
News
Nan Goldin was among the artist-activists who gathered in Washington, DC to demand the FDA address the "public health impact of the opioid crisis."
News
The art philanthropist family, though not named in the lawsuit, will contribute $75 million to fund a new addiction treatment and research center at Oklahoma State University in Tulsa.
In Brief
The suspension follows last week's announcements that the Guggenheim and Tate will no longer accept funds from the Sackler family.
News
The announcement follows a similar decision by Tate, announced yesterday, that the institution will no longer accept funds from the Sacklers, owners of Purdue Pharma.